Variant report

Variant	rs61977576
Chromosome Location	chr14:24298882-24298883
allele	A/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	FOXA2	chr14:24298750-24299084	HepG2	liver:	n/a	n/a
2	FOXA1	chr14:24298756-24299111	HepG2	liver:	n/a	chr14:24298860-24298875

No.	Distal block	Cell Line	Cell type
1	chr14:24293571..24296488-chr14:24298769..24300943,3	MCF-7	breast:
2	chr14:24293705..24296487-chr14:24298794..24300762,2	K562	blood:
3	chr14:24137621..24139131-chr14:24297384..24299665,2	MCF-7	breast:
4	chr14:24285592..24288155-chr14:24298380..24300344,2	K562	blood:

Variant related genes	Relation type
ENSG00000258887	TF binding region

Extended variants
information (count: 12 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:8)

rs_ID	r²[population]
rs11624116	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs11627053	0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs11627556	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs35538963	0.88[AMR][1000 genomes];0.93[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs61977197	0.88[AMR][1000 genomes];0.95[EUR][1000 genomes]
rs61977574	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs61977575	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs61977577	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:4 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1043299	chr14:23766696-24351724	Active TSS Enhancers Flanking Active TSS Weak transcription Genic enhancers Transcr. at gene 5' and 3' Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	104 gene(s)	inside rSNPs	diseases
2	esv3405661	chr14:24189883-24670942	Strong transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	131 gene(s)	inside rSNPs	diseases
3	nsv564045	chr14:24224245-24348343	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	6 gene(s)	inside rSNPs	diseases
4	nsv901494	chr14:24243637-24386159	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	9 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:32 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:24295800-24302000	Enhancers	Primary monocytes fromperipheralblood	blood
2	chr14:24296400-24299800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
3	chr14:24296400-24302000	Enhancers	Primary hematopoietic stem cells short term culture	blood
4	chr14:24296400-24302000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
5	chr14:24296600-24301200	Enhancers	HSMMtube	muscle
6	chr14:24296600-24301800	Enhancers	HSMM	muscle
7	chr14:24297000-24299000	Enhancers	Primary hematopoietic stem cells	blood
8	chr14:24297200-24301000	Enhancers	Hela-S3	cervix
9	chr14:24297400-24299200	Enhancers	Colon Smooth Muscle	Colon
10	chr14:24297400-24299200	Enhancers	Rectal Mucosa Donor 29	rectum
11	chr14:24297400-24301600	Enhancers	Muscle Satellite Cultured Cells	--
12	chr14:24297600-24299800	Enhancers	Rectal Smooth Muscle	rectum
13	chr14:24297600-24300400	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
14	chr14:24297600-24300400	Weak transcription	Ovary	ovary
15	chr14:24298200-24300200	Enhancers	NHDF-Ad	bronchial
16	chr14:24298400-24299200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
17	chr14:24298400-24299200	Bivalent Enhancer	HepG2	liver
18	chr14:24298400-24300000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr14:24298400-24300000	Enhancers	HMEC	breast
20	chr14:24298400-24300600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
21	chr14:24298600-24299000	Weak transcription	Placenta Amnion	Placenta Amnion
22	chr14:24298600-24299200	Flanking Active TSS	A549	lung
23	chr14:24298600-24300000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
24	chr14:24298600-24300000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
25	chr14:24298600-24300000	Enhancers	HUVEC	blood vessel
26	chr14:24298600-24300000	Enhancers	NH-A	brain
27	chr14:24298600-24300000	Enhancers	NHEK	skin
28	chr14:24298600-24300200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
29	chr14:24298600-24300600	Enhancers	Osteobl	bone
30	chr14:24298800-24299000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
31	chr14:24298800-24300800	Weak transcription	Small Intestine	intestine
32	chr14:24298800-24301000	Enhancers	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links